跳至主要内容
临床试验/NL-OMON42497
NL-OMON42497已完成不适用

terine Cervix repeated Magnetic Resonance Imaging for adaptive treatment planning of cervical cancer radiotherapy. A single-center study - CeReMony

niversitair Medisch Centrum Utrecht0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Clinical indication for chemoradiotherapy with curative intent (one of the following):
  • -FIGO [1] stage IA, IB1 or IIA1 cervical cancer with regional lymph node pathology,
  • -FIGO stage IA, IB1 or IIA1 cervical cancer with contraindications for surgery
  • -FIGO stage IB2, IIA2, IIB, IIIA, IIIB, or IVA cervical cancer
  • * Medical condition that allows chemoradiotherapy with curative intent
  • * Age * 18 years
  • * Signed informed consent, obtained before the acquisition of the first additional MRI scan
  • * Able to comply with the variable bladder filling protocol (drinking and voiding instructions, this protocol is part of standard clinical care)

排除标准

  • * Patients who meet exclusion criteria for MRI at 1.5T following the protocol of the department of Radiology of the UMC Utrecht
  • * Patients who are mentally or otherwise disabled and/or considered legally incapable
  • * History of previous pelvic radiotherapy
  • * Pregnant or breast-feeding patients

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验